Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs-reducing global inequity.

Lancet Glob Health

Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands; ReSViNET Foundation, Zeist, Netherlands.

Published: October 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2214-109X(24)00258-4DOI Listing

Publication Analysis

Top Keywords

access highly
4
highly effective
4
effective long-acting
4
long-acting rsv-monoclonal
4
rsv-monoclonal antibodies
4
antibodies children
4
children lmics-reducing
4
lmics-reducing global
4
global inequity
4
access
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!